High yield of endoreduplication induced by ICRF-193:: a topoisomerase II catalytic inhibitor

被引:17
|
作者
Pastor, N [1 ]
Flores, MJ [1 ]
Domínguez, I [1 ]
Mateos, S [1 ]
Cortés, F [1 ]
机构
[1] Univ Seville, Fac Biol, Dept Cell Biol, E-41012 Seville, Spain
关键词
endoreduplication; diplochromosomes; topoisomerase II; ICRF-193; EM9;
D O I
10.1016/S1383-5718(02)00029-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
An uncommonly high yield of spontaneous endoreduplication is a feature of the CHO mutant EM9, besides its defective repair of single, as well as double-DNA strand-breaks and its extraordinarily elevated yield of sister chromatid exchanges (SCEs) after bromodeoxyuridine (BrdU) incorporation into DNA. Since the nuclear enzyme topoisomerase II (topo II) has been reported to be responsible for the segregation of daughter chromosomes during mitosis, in the present investigation we have made use of the bisdioxopiperazine ICRF-193, a topo II catalytic inhibitor that interferes with the normal turnover of the enzyme. In order to see whether both EM9 cells and its parental cell line AA8, which show differences in the spontaneous frequency of endoreduplicated cells are or not equally sensitive to the topo II catalytic inhibitor, both cell lines have been treated with a range of doses of the bisdioxopiperazine. Our results show that both cell lines respond to the treatment entering in an endoreduplication cycle, but the EM9 cells are extremely sensitive to the inhibition of topo II. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 50 条
  • [21] DNA TOPOISOMERASE-II IS THE MOLECULAR TARGET OF BISDIOXOPIPERAZINE DERIVATIVES ICRF-159 AND ICRF-193 IN SACCHAROMYCES-CEREVISIAE
    ISHIDA, R
    HAMATAKE, M
    WASSERMAN, RA
    NITISS, JL
    WANG, JC
    ANDOH, T
    CANCER RESEARCH, 1995, 55 (11) : 2299 - 2303
  • [22] Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
    Hana Bavlovič Piskáčková
    Hana Jansová
    Jan Kubeš
    Galina Karabanovich
    Nela Váňová
    Petra Kollárová-Brázdová
    Iuliia Melnikova
    Anna Jirkovská
    Olga Lenčová-Popelová
    Jaroslav Chládek
    Jaroslav Roh
    Tomáš Šimůnek
    Martin Štěrba
    Petra Štěrbová-Kovaříková
    Scientific Reports, 11
  • [23] ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cells
    Iwai, M
    Hara, A
    Andoh, T
    Ishida, R
    FEBS LETTERS, 1997, 406 (03) : 267 - 270
  • [24] Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin
    Cantero, G.
    Campanella, C.
    Mateos, S.
    Cortes, F.
    MUTAGENESIS, 2006, 21 (05) : 321 - 325
  • [25] Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action
    van Hille, B
    Etiévant, C
    Barret, JM
    Kruczynski, A
    Hill, BT
    ANTI-CANCER DRUGS, 2000, 11 (10) : 829 - 841
  • [26] EFFECT OF ICRF-193, A NOVEL DNA TOPOISOMERASE-II INHIBITOR, ON SIMIAN VIRUS-40 DNA AND CHROMOSOME-REPLICATION INVITRO
    ISHIMI, Y
    ISHIDA, R
    ANDOH, T
    MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (09) : 4007 - 4014
  • [27] The DNA topoisomerase II catalytic inhibitor merbarone is genotoxic and induces endoreduplication
    Pastor, Nuria
    Dominguez, Inmaculada
    Luis Orta, Manuel
    Campanella, Claudia
    Mateos, Santiago
    Cortes, Felipe
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2012, 738 : 45 - 51
  • [28] ICRF-193 modifies etoposide-induced apoptosis in thymocytes
    Tanimoto, C
    Hirakawa, S
    Kawasaki, H
    Hayakawa, N
    Ota, Z
    ACTA MEDICA OKAYAMA, 1995, 49 (06) : 281 - 286
  • [29] Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells
    Beere, HM
    Chresta, CM
    Hickman, JA
    MOLECULAR PHARMACOLOGY, 1996, 49 (05) : 842 - 851
  • [30] DNA topoisomerase II as the cellular target of a novel antitumor agent ICRF-193, a bisdioxopiperazine derivative, in Xenopus egg extract
    Sato, M
    Ishida, R
    Ohsumi, K
    Narita, T
    Andoh, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) : 571 - 575